Curious Reactor, the AI built by founder Jenny Ro, PhD, helps participants at life science conferences figure out who to meet. It's only the first step in a promising road map. Loved the chat with this compelling founder.
Highlights from the interview:
Sal’s Intro for Jenny Ro, PhD
What Curious Reactor Does
The Founding Story of Curious Reactor
“…a lot of the ideas that we generate, only less than 5% actually makes it out to door of university.”
Curious Reactions that Led to a Cancer Cure
“So, I would like to think Curious Reactor is part of that new wave of technology where it can democratize the skillset that lot of people with high emotional intelligence currently have.”
“…value to the conference organizer is essentially that, that we make the experience in their venue much more attractive compared with any other competitors.”
Sal Talks About His Investment Syndicate
How Jenny Ro Became an Entrepreneur
Jenny Ro Actually Commercialized a Technology During Her PhD Studies
How the Name “Curious Reactor” Came About
Parting Thoughts from Jenny Ro, PhD
Transcript
Sal’s Intro for Jenny Ro, PhD
Sal Daher: Welcome to Angel Invest Boston. I'm Sal Daher, your host an Angel Investor who delights in the technology startups being built in Boston's singular startup ecosystem. Boston is full of startup ideas, and as an investor, I have the opportunity to invest early in some really, really interesting companies. I have the good fortune to have as a guest today, Jenny Ro.
Jenny Ro: Hi, Sal.
Sal Daher: Good to have you.
Jenny Ro: Good to be here.
Sal Daher: We are recording this during the time of COVID-19. So unfortunately I don't have the benefit of Raul Rosa, my sound engineer, in studio to help me out. So the listeners should be bearing with the hassles. Raul will try to clean things up afterwards, but we can't expect perfection.
Anyway, Jenny, great that you're on. Jenny Ro is a PhD scientist. She did a PhD in molecular and cellular biology. She did a postdoc at Harvard Medical School and she's worked in technology transfer. So she's been a researcher, technology transfer, she's worked in making labs more efficient, and all along she's sort of been developing this passion for funding of biotech companies. So she has a startup called Curious Reactor, and I'd love to have her tell me about the startup. So Jenny, please tell us what Curious Reactor does and why it's so important.
What Curious Reactor Does
Jenny Ro: Thank you, Sal. Curious Reactor is a SaaS platform and we make human connections that resembles a human super connector. You can imagine that as one of your colleagues or mentors who seems to always know who to connect you when you're stuck on something or looking for specific people to connect. Obviously that is very important and the startup being connected to the right investors in a biotech and pharma industry.
Sal Daher: Would you care to share with us the founding story of Curious Reactor, how you came about starting the company?
The Founding Story of Curious Reactor
Jenny Ro: Yeah, of course. I'm a trained scientist and I always aspired to be a researcher in academia and I was on that track until a Harvard postdoc fellow. What I realized throughout my training is that a lot of the knowledge that we generate as a scientist really doesn't get to make a big impact in the world in most efficient way.
“…a lot of the ideas that we generate, only less than 5% actually makes it out to door of university.”
So, for example, a lot of the ideas that we generate, only less than 5% actually makes it out to door of university. Even if they get out, it takes about 10 to 25 years to make an impact. So if that is therapy, it takes 10 to 25 years essentially to get to the patients. That is a really sad reality. And as a scientist, I just couldn't believe and I wanted to make an impact to shorten that and more ideas to get out.
Sal Daher: Okay. And so I understand there was a particularly moving case, which got you off the mark on creating Curious Reactor?
Curious Reactions that Led to a Cancer Cure
Jenny Ro: Right. So I serendipitously stumbled into the panel discussion about two years ago, and it was a story of a lung cancer survivor. Her name is Linnea Olson, and three other peoples and how their life has been intertwined for the last 12 years to create these life-saving drugs, and three of them in 12 years. And long story short, a pivotal moment for their discovery and all came down to human connection. So Linnea was introduced to the right oncologist at the right time, which oncologist was connected to the right researcher who was developing a new drug. And the result of that was a miracle. So she was supposed to only live five to six months and she is currently with us 15 years later.
Sal Daher: A wonderful outcome.
Jenny Ro: Yeah. And that story really inspired me and realize it's all about people. And if we can actually make that human connection more efficient and wide, we can actually create more miracles. And the outcome of that will be more breakthrough ideas, getting into the world and shorten the time to patients.
Sal Daher: I'm all for that, because you are entirely right. There's a lot of work that gets done in the lab and getting it out to the world is a very, very difficult process. There's so many reasons for it. And part of the solution, a very important part of the solution I think, is making the right connections. So I think you are a dog barking up a tree that has many squirrels in it.
Jenny Ro: My dog will like that.
Sal Daher: So, it's the right tree. Your dog would like the show. Jenny's a dog person. So everything with my making the dog comparison here. Now explain to me how it works. Do you have some sort of cases where you've connected people?
Jenny Ro: We are early stage and what we essentially have now I would say is a engine without a car. So we developed a special matchmaking algorithm that can predict who needs to meet who based on their pressing needs or the problem that they're dealing with that mimics the way that your well-connected colleague works.
So if you were to put it in an analogy, that would be people finding a lifesaving molecule without a drug delivery system, and they basically need to have that packaging in order to deliver. So I'm currently engaging with the strategic partner who has that delivery to get to people and make an impact, but within a year or so we should be able to productize fully.
Sal Daher: Interesting. Now, can you sort of generically tell me what this partner does, and what that partner brings to the equation?
Jenny Ro: Yeah, so what's really important for us is that we are a small player and don't have enough brand recognition or reach to get to as many people as we want to connect. So we've been working with a lot of local conferences or events that aggregates the large number of people who self-identified as wanting to network and expand their professional networks. So we partner with those organizers to deliver one-on-one curated matching within their attendees or any other community organizer or community builder who has visibility across 70 to 100,000 people through a mailing list or newsletter and provide their community a connectivity.
Sal Daher: Okay, okay. So you have a piece of software that can look at various attributes that people have and kind of match them up with the right people that could help them with the project they're working on?
Jenny Ro: Correct.
Sal Daher: It prompts me when we're off mic, remind me that I have an idea of someone I should connect you with.
Jenny Ro: See, this is how this is how super connector's brain work. And that's our algorithm is trying to mimic.
Sal Daher: Yeah, I'm thinking about someone who runs a lot of biotech conferences, who is a friend of mine-
Jenny Ro: That would be awesome.
Sal Daher: ... yeah, and he's a sort of a person who has a very open mind, and is very curious, so. Okay, so basically your hope is that you'll be able to discern. Let's say there's a scientist that has a particular technology that she's developed in a lab, and there's a whole process that she has to go through because she's a researcher for the institution. She needs to figure out how she takes her technology out of the lab. She needs how to license it. She wants to maximize in the work she can do under grants. At the same time she wants to be building intellectual property in her own company. And there's this whole tension, a very fine balancing act. I'm actually thinking of a real person who's actually done, I've interviewed on the podcast. And you know, that's one thing that people need to go through. Never mind meeting of that she also had to connect with investors to help her basically prove out the first steps of that to the point where she now has VC funding to the tune of something like I think $15 million that she is going to do a bunch of human trials. And at the end of those, it is hoped that some strategic player will take an interest in the technology that she's developed. She is a super connector herself. She's somebody who is brilliant at connecting with people. And she has a TEDx talk, which has gotten last time I checked 1.3 million views. The other thing is also, you need to bring in people into your project in addition to investors and so forth. Because it requires a very different set of skills to develop a technology in the lab then taking it into commerce.
Jenny Ro: Correct.
Sal Daher: And scientists tend to not understand what it means. This is one of the common complaints.
Jenny Ro: It's okay.
Sal Daher: Jeff Arnold, who's a very successful biotech investor, I've interviewed him on the podcast, and his episode is called “How to Make Money in Biotech”. He says, "One of the things you've got to watch out for is that scientists do not understand what it means for something to work." Lab conditions; it works under ideal conditions in a lab with very careful, meticulous PhD scientists in a perfect environment. They don't know that the real world is very different and they don't think about it. I've seen cases of this. I've seen people use up entire rounds of funding because they miss that little subtlety. But they're also able to recover and to sort of say, "Oh yeah, that was a dead end. Now we need to do this a different way, we're really not ready."
So, this is one of the big, big things. And I think Jeff is correct. And I have seen it myself in the companies that I've invested in. You need to bring in people who understand the process of taking stuff from a lab and into the clinic or from the lab into manufacturing and so forth. And scientists, I fault some scientists were being kind of like a little bit, know it all sometimes. I mean, by definition, I mean, not you I'm sure, because you're a-
Jenny Ro: No, lot of them are-
Sal Daher: You're very broad, worldly scientist, very worldly scientist.
Jenny Ro: A lot of us are guilty of that. So I have been guilty of all [inaudible 00:10:48] before.
Sal Daher: No, no, no, but the very best scientists, what does it mean? They're really good at doing work that gets the approbation of his or her peers, right?
Jenny Ro: Yep.
Sal Daher: And they can't deal with rejection. I'm having a conversation with someone right now that has an excellent idea. They have software that works and so forth, but it just cannot get around the fact that he wants to lead this thing. And he's a scientist, he's worse than a scientist, he's a mathematician, and an applied mathematician. Wants to lead the company, he needs to let up and to bring somebody else to lead the company. And he needs to be the guy leading the development effort. I'm not going to say his name, but if he hears it, he'll know I'm talking about him.
Jenny Ro: There's too many of them that resonates with this story, I think.
Sal Daher: This is a problem, it really is. They need to be coachable. They need to kind of accept that they're in a new area. They're not the big expert anymore. It's worse than that, they're in an area where no one is an expert, this thing hasn't been done before. So you have to have a very open mind, attitude of discovery.
Jenny Ro: I want to actually point it out that I think what you just describe is a life of about 10 years’ worth of one scientist's life. If you were to think about it, you described it as a discovery science in university, licensing out to biotech and all the way down to getting to the right people for exit. And that actually amounts to about 10 to 25 years. And that includes meeting hundreds of thousands of people to push that endeavor for. We've got to meet the right investors, collaborators.
Sal Daher: I would say hundreds, if not thousands.
Jenny Ro: Correct. Yeah, so that's exactly the same, the process that I would like to help.
Sal Daher: Yeah. So it's broader than funding?
Jenny Ro: Correct.
Sal Daher: It has to be advisors. It has to be people that you hire. I'm on a board of a biotech right now, and they are the most advanced biotech company, basically three years in that I've ever seen in terms of governance and all this stuff. Because a lot of these companies, I mean, they don't have a board, they don't have anything. And yet people who are not in the field, they look at and say, "Oh, these guys, they don't have anything." So you kind of have to look at these things with the proper lens. You have to understand that a three-year-old company is not going to be fully formed and you have to adjust for what you're dealing with. Jenny, would you like to talk a little bit about what you anticipate? Is this a company too so you could build into something, create an exit for an investor for example?
Jenny Ro: Yes.
Sal Daher: Is this an investible company?
Jenny Ro: Yes, I do. So I would like to kind of in broad sense think about where Curious Reactor fits in the whole world. And my vision is that if you were to think about all the technology in big company in 21st century, like Google or Facebook, what they enable in the world is basically democratizing IQ. That's how I like to think about it because they provided an infrastructure and access to the knowledge that formally hundreds or thousands of years ago only the really well educated people that read books and that's all they did, had an access to. Now, if you can type and ask a simple question, you have access to that knowledge at your fingertip, but-
Sal Daher: Yes and no.
Jenny Ro: Yes.
Sal Daher: I must disagree with you here. It's yes and no.
Jenny Ro: Okay.
Sal Daher: Here's a curious fact. I don't know where I read this, but the quality of Google searches varies tremendously by the amount of prior knowledge that the searcher has. So people who know more, do far more effective Google searches than people who know less.
Jenny Ro: That is true, but I think still the gradient between the people who read a lot and consumed that knowledge by themself by going through higher education for you're having five different PhDs versus lay audience. I think that gradient is still getting smaller and smaller because of access to these knowledge. But I would like to think about in future, what's next after that. And I think we hear this a lot these days that whoever can tap into emotional intelligence, which is still largely centralized to people with a great human skills with high EQ are able to utilize it. And what those people are really good at is actually building human relationship.
“So, I would like to think Curious Reactor is part of that new wave of technology where it can democratize the skillset that lot of people with high emotional intelligence currently have.”
So, I would like to think Curious Reactor is part of that new wave of technology where it can democratize the skillset that lot of people with high emotional intelligence currently have.
Sal Daher: Okay.
Jenny Ro: I definitely think that the technology that we developed can be utilized in multiple ways. So the use case in conference is one way, but I would like to consider ourself as a customer relationship generator, as opposed to customer relationship manager, CRM. So it can be part of the marketing outreach algorithm that will let you hyper focus on the right audience and engage with your customers differently. So there's many ways that can be utilized and we are actually partnering with a couple of the companies to test that out.
Sal Daher: Okay. How do you hope to capture some of that value in your company so that you can build value in your company? I can see how you could be building value for your partners. Are you charging for the service? Is it a subscription or are you charging based on ideas generated? I don't know how you measured that.
“…value to the conference organizer is essentially that, that we make the experience in their venue much more attractive compared with any other competitors.”
Jenny Ro: Right. It's difficult. So, in terms of the conference organizer, what we essentially provide is a compelling reason for repeat business. Because a lot of people go back to the same conference over and over, the ones that they had develop the meaningful relationship with. So in terms of value to the conference organizer is essentially that, that we make the experience in their venue much more attractive compared with any other competitors. So the value to them is going to be business.
For the enterprise customers who are utilizing us as a customer relationship generator, what we essentially do is if you were to think about the sales funnel, all the way from contact to closing sales, we are at the very beginning from contact to opportunity generation. So in the industry standard that conversion rate is currently 11%. But if you are to make the first contact in much more meaningful way with your customer, you can boost that 11% conversion rate to something else that will lead you to much higher revenue generation down the road.
Sal Daher: Wow, okay.
Jenny Ro: And that would be part of our service fee for the enterprise customers.
Sal Daher: I'm just amazed that a PhD scientist, a physical scientist knows what a sales funnel is. I'm amazed.
Jenny Ro: Well, it's interesting, because for me it's nothing more than a data-driven thinking. So I mean, scientists are really good at trying to think, this is the data, if you were to create a different outcome, what's the input points going to be? So if I were to think about marketing and sales, which I actually had to learn quite a bit throughout my entrepreneurial journey, it's basically that.
Sal Talks About His Investment Syndicate
Sal Daher: Okay. That's very good. So, I'm going to ask Jenny Ro coming up, how an investor would make money investing in Curious Reactor? But first, let me just talk a little bit about my investment syndicates. Investments syndicates, basically it's a list of people who are accredited investors who are interested in investing in early stage companies. Jenny, this is how I help fund biotech startups, okay? For example, I have an LLC that invests in one of my favorite companies, I'm on the board of this company, or soon to be on the board of this company, called Savran Technologies. They are a cell separation company. These guys are like extreme cell separation, not just like your regular run of the mill cell separators. These guys are like a 100 X better than your regular cell separators. If you have a 10 milliliter tube of blood, like your regular blood draw, you have a billion cells in there.
If there are five cells that you are looking for, they will find four or five of them. Let's say a circulating tumor cell. In the billion cells they'll find four or five cells. That's how good at capturing cells they are. And they will put those four or five cells in little wells. And then you can take those cells and you can sequence them. You can culture them, you can do all kinds of things to them. It's a platform technology, I love platform technologies. And they have actually discovered the really, really hot use for their technology, which happens not to be in the circulating tumor cancer cell. I mean, that's the technology that's going to be developed over time and it is useful, they're maturing it and so on.
But the real hot button for them is the capture of fetal cells. And Jeff Behrens, who has been on this podcast has talked about this. And I just think it's the most exciting company there is. And so, I help support Savran by investing my own money. I have also brought in people who are accredited investors to invest into this company.
I'm not currently raising money and this is not an attempt to raise money, but this is an attempt to explain something that I have done for this company. And so if you're interested in investing in companies such as Savran, or companies that have a great deal of potential, I happen to like these types of platform technologies. I was an early investor in SQZ Biotech for example, which is a very tremendously effective way of transforming cells. And those guys are off to the races, they're doing amazing things. Their work has been validated by over a billion dollar deal with Roche and other strategic partners.
And so, I see companies like that in Boston, and that's a reason why you should sign up at my Syndicate list. You just go to my website, angelinvestboston.com and you see Syndicates, put your name in there, do the accredited investor questionnaire. And then we can talk to you about the current opportunities.
Anyway, so Jenny, how would an investor make money if they put money into Curious Reactor? Not that you're raising money right now, but if you were, how would they make money?
Jenny Ro: Yeah. I think Curious Reactor is developing a really exciting technology that has multiple use to it. So I consider it as a platform technology in some way, because we can productize it in multiple ways.
Sal Daher: Ah, okay.
Jenny Ro: So, we are very capital efficient and already have generated revenue. It's a hockey stick in a logarithmic form is how I like to describe it. But we're very capital efficient, we are making money through engagements that we have, either through strategic partnership. And we have a plan to be hitting the main revenue stream by year or two. And that has a potential to go into multiple industry vertical, not only in the life science business, but all different innovation ecosystem.
Sal Daher: Would there be an exit? Is there a strategy for an exit for the investors?
Jenny Ro: Yes. So for me the most logical step is there are, currently there's a lot of strong players in customer relationship management or customer experience, your marketing agencies who cares a lot about helping relationship building. And I consider Curious Reactor fits right in front of their current process. So that would be a logical exit for us.
Sal Daher: Okay, let's talk about how you decided to become an entrepreneur. Where were you born? Where did you grow up, Jenny?
How Jenny Ro Became an Entrepreneur
Jenny Ro: I was born in Long Island, New York, but I grew up in South Korea. And I think I've always been such a kind of a nerdy kid and always been really into science and biology and loving outdoors. But looking back on it, I always have been very entrepreneurial. So my first business, if I were to recall was, I was a seven-year-old and I was a distributor for beansprouts from my neighbor who grew delicious beansprout, yet she wasn't very mobile. And I was a six-year-old kid who had more energy than I can handle. So I started distributing those beansprouts to other households who wants to buy it. And I took a cut on the delivery fee.
Sal Daher: Woo ha, a good start.
Jenny Ro Actually Commercialized a Technology During Her PhD Studies
Jenny Ro: Yeah. But yes, so that was sort of ... I was always entrepreneurial like that. But the first real formal experience of running a business is actually, during my PhD I had my own invention, which didn't get patent or went through a traditional route of technology transfer as you can imagine. But I actually took that invention as an open source technology and commercialized it myself with an industry partner. And it's in the shelf of Sable Systems International, our industry partner who commercialized my device. And that really opened my eyes in many aspects of running a small business and being an entrepreneur and academic inventor.
Sal Daher: I don't know exactly what Sable International does, but I was intrigued by effect, one of the descriptions is, mouse respirator and treadmill.
Jenny Ro: Correct.
Sal Daher: Mouse metabolism and stuff like that.
Jenny Ro: Yep, yep. So I mean, as you can imagine, so the rodents is really important biomedical model system-
Sal Daher: Yes.
Jenny Ro: ... and it's really important to study the whole organismal physiology and Sable Systems International basically provide you with the portfolio of equipments and different type of support to measure all aspects of animals. How long they live to how much they ... What their metabolism is to all sorts of aspects, so.
Sal Daher: And it's an adventure that you did when you were doing your PhD at the University of Michigan?
Jenny Ro: Correct, yes.
Sal Daher: As my old business partner would say, my late business partner used to say, “mazel tov, kiddo." Impressive. Very impressive. Very impressive. So, you had this sort of early entrepreneurial itch, and I understand that you worked in technology transfer for a while. I see in your resume that you had a venture where you were consulting with labs, helping labs, "If you have things that you were doing over and over and over, let's talk." Please tell me about that business.
Jenny Ro: Yeah. So that's actually the entity that I use to commercialize my own invention from University of Michigan. It's called Flidea. The invention that I created basically was lot of ... So scientists are very good at coming up with methodologies or new equipments to make their work faster. So a lot of the device that I created along with my advisor and lab mates were essentially automating a lot of our workflows in the lab dealing with animal research. So I realized that skillset that we had collectively is very marketable for many other scientists to commercialize a lot of their own homemade inventions. So we will take that idea and put it through a rapid prototyping within our expertise and be able to commercialize it, either through Flidea or by partnering with other industry partners.
Sal Daher: Very interesting. Very interesting. And so that is a venture that you're still involved with? I mean, you work in the business development side of it, you're not involved operationally?
Jenny Ro: Correct. So interestingly my old advisor, who does most of the product development for that, because he is the brain behind a lot of the invention for the current development and I be the operational side. So I engage with potential customers or land industry collaborative research projects that we can work with.
Sal Daher: This is fascinating. This is really fascinating. So, I understand that there is a promotion going on with Curious Reactor, please address yourself to the potential buyers of this, people who are sponsoring, people who are organizing conferences. Who else would be a buyer of this?
Jenny Ro: With the current pandemic I understand that expanding your professional network is very challenging.
Sal Daher: Yes.
Jenny Ro: So, living in a Boston, actually for me, the easiest things as a business developer in the industry is to just walk out of my apartment and just go to one of the venues that I know will have networking events. Well, now that's not possible. So how do you expand your professional network while we're all staying at home during pandemic? And I think this is going to be true for many more months to come. So we are running a promotion in public to help people expand their network by filling out one of our surveys. So this would have been what you would have filled out if you were to participate in one of the events or conferences that Curious Reactor partner with. Usually the process would have been during your registration to the event, you would have filled out a pre event questionnaire that is prepared by us. And then we would have told you that you should talk to X, Y, and Z and give you a cheat sheet for networking when you're walking into the event room. So instead of that-
Sal Daher: Oh, cool.
Jenny Ro: ... we're opening up that questionnaire to a general public. And if you fill that out, you will receive an email from us when we find the right match among others who have filled out that questionnaire. And you'll be able to meet stranger without leaving a home.
Sal Daher: That's so cool. Well listeners, take this to heart. Jenny is very serious at what she's doing. I plan to fill it out, because I'm always interested in having more people who might be listeners to the podcast and more people who might be investors in my syndicates. So I'm going to fill it out and see what happens. Keep my fingers crossed.
How the Name “Curious Reactor” Came About
I'm really curious how you got this, the main name, curiousreactor.com. Yeah, you must've paid a fortune for it?
Jenny Ro: No, actually that was our criteria that we need to pick a dot com domain name that fits our budget, which was like 15 bucks two years ago. And we got to land on that and there's actually a funny story behind it. I was invited to give a talk in London in the premise of the business I was building, and I didn't have a name or a business card or anything like that. We had to have an urgent meeting with, I had two other business partner back then, one was a developer and one was my current business partner. And three of us, we put our heads together and we had to come up with a name and print the business cards, so.
We start throwing words and different vocabularies that describe what we thought we were. And our developer basically wrote a little script to figure out whether whatever name that me and my business partner came up with and whether that was available in a dot com domain in a really automated way and automatically checking a thesaurus for it. And what we wanted to really capture was we wanted people to feel like they're going to find something serendipitously happy. But at the same time, like a nuclear reactor, but fueled by curiosity, so. A lot of interesting things would come out of that reactor, and that's where we ended up. We dodged the bullet of becoming a fluke reactor or something like that, because that was one of our thesaurus and available-
Sal Daher: Fluke [crosstalk 00:31:53].
Jenny Ro: ... in dot. Yeah.
Sal Daher: Not good, fluke [crosstalk 00:31:56].
Jenny Ro: I know. I know, but that's available in dot com.
Sal Daher: Oh my gosh, yeah. That is a funny story.
Jenny Ro: Yeah. And we're happy with it. I really love the name and I think it encapsulates what we do.
Sal Daher: Take a moment and think what you would like to say to our audience of people who are ... I've recently discovered that my audience is skewing very young, something like 54% of my audience is between 25 and 38.
Jenny Ro: Wow.
Sal Daher: It's really as much ... I guess the oldsters have stopped listening. I don't know what's happened.
Jenny Ro: Or they're getting younger.
Sal Daher: This is all young people. They're getting younger. A fountain of youth has been discovered in my podcast.
Jenny Ro: Yes.
Sal Daher: Listen to my podcasts, you're going to get younger. And also I used to think that the listenership was one third women. I'm glad to hear that it's something like 40 something percent women now.
Jenny Ro: Oh wow.
Sal Daher: Yeah. I'm very happy to hear. Recent stats that I've just looked at. So anyway, if you'd like to address, there are people who work at startups and founders and some investors. What would you like to communicate to them?
Parting Thoughts from Jenny Ro, PhD
Jenny Ro: First off, keep up the great work, because I think we need help from all innovators to move new bright future. And I think networking is really important and expanding your professional network and building meaningful relationship and more working relationship is really important. And Curious Reactor, I hope that we can play a role in that and making your life a little bit easier and be able to introduce you to people that you didn't have access to before. So reach out to us. Our website is curiousreactor.com.
Sal Daher: Excellent. Excellent. I encourage people to reach out to the website. I will go on the website myself and put in my references and hope to get some curious and interesting connections. Well, Jenny Ro, I am very grateful to you for making the time to be on the podcast.
Jenny Ro: Thank you so much, Sal.
Sal Daher: Great. This is Angel Invest Boston. I'm Sal Daher.
Sal Daher: I'm glad you were able to join us. Our engineer is Raul Rosa. Our theme was composed by John McKusick. Our graphic design is by Katharine Woodman-Maynard. Our host is coached by Grace Daher.